Keywords: ppl, therapeutics, half-year, results, first, public-quoted, company
PPL Therapeutics Half-Year Results
Article | 23 September 1996
- PPL Therapeutics' first results as a public-quoted company (Marketletter June 10) show half-year revenues of L2.1 million ($3.3 million), down 36.3%, with operating ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
